Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis

被引:89
作者
Mok, Chi Chiu [1 ]
Birmingham, Daniel J. [2 ]
Leung, Hoi Wah [1 ]
Hebert, Lee A. [2 ]
Song, Huijuan [2 ]
Rovin, Brad H. [2 ]
机构
[1] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Ohio State Univ, Med Ctr, Dept Med, Columbus, OH 43210 USA
关键词
vitamin D; atherosclerosis; cholecalciferol; disease activity; traditional risk factors; NUTRITION EXAMINATION SURVEY; 25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; CARDIOVASCULAR RISK; 1,25-DIHYDROXYVITAMIN D-3; AUTOIMMUNE-DISEASES; NATIONAL-HEALTH; D-RECEPTOR; SLE; PREVALENCE;
D O I
10.1093/rheumatology/ker212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To study the relationship of 25(OH)D-3 level with disease activity, vascular risk factors and atherosclerosis in SLE. Methods. Consecutive patients who fulfilled four or more ACR criteria for SLE were recruited for assay of 25(OH)D-3 level. Disease activity was assessed by the SLEDAI and physicians' global assessment (PGA). Patients with vascular risk factors were screened for atherosclerosis at the coronary or carotid arteries. Correlation between 25(OH)D-3 levels and SLEDAI scores was studied by linear regression. The link between vascular risk factors, atherosclerosis and vitamin D deficiency was also examined. Results. A total of 290 SLE patients were studied [94% women; mean (s.d.) age 38.9 (13.1) years; disease duration 7.7 (6.7) years; 78% patients had clinical or serological lupus activity]. Two hundred and seventy-seven (96%) patients had vitamin D insufficiency [25(OH)D-3 < 30 ng/ml] and 77 (27%) patients had vitamin D deficiency (< 15 ng/ml). Levels of 25(OH)D-3 correlated inversely with PGA (beta -0.20; P = 0.003), total SLEDAI scores (beta -0.19; P = 0.003) and subscores due to active renal, musculoskeletal and haematological disease. Subjects with vitamin D deficiency had significantly higher total/high-density lipoprotein (HDL) cholesterol ratio [3.96 (2.94) vs 3.07 (0.80); P = 0.02] and prevalence of aPLs (57 vs 39%; P = 0.007). Of 132 patients, 58 (44%) with vascular risk factors screened were positive for subclinical atherosclerosis. No association could be demonstrated between 25(OH)D-3 level and atherosclerosis, which was mainly associated with increasing age, menopause, obesity and hyper-triglyceridaemia. Conclusions. In this large cross-sectional study of SLE patients, 25(OH)D-3 level correlates inversely with disease activity. Vitamin D deficiency is associated with dyslipidaemia. In patients with vascular risk factors, subclinical atherosclerosis is not associated with hypovitaminosis D.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 36 条
[1]   Update in Vitamin D [J].
Adams, John S. ;
Hewison, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02) :471-478
[2]   Control of autoimmune diseases by the vitamin D endocrine system [J].
Adorini, Luciano ;
Penna, Giuseppe .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (08) :404-412
[3]   Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? [J].
Amital, H. ;
Szekanecz, Z. ;
Szucs, G. ;
Danko, K. ;
Nagy, E. ;
Csepany, T. ;
Kiss, E. ;
Rovensky, J. ;
Tuchynova, A. ;
Kozakova, D. ;
Doria, A. ;
Corocher, N. ;
Agmon-Levin, N. ;
Barak, V. ;
Orbach, H. ;
Zandman-Goddard, G. ;
Shoenfeld, Y. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) :1155-1157
[4]   Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population [J].
Anderson, Jeffrey L. ;
May, Heidi T. ;
Horne, Benjamin D. ;
Bair, Tami L. ;
Hall, Nathaniel L. ;
Carlquist, John F. ;
Lappe, Donald L. ;
Muhlestein, Joseph B. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07) :963-968
[5]   Vitamin D: modulator of the immune system [J].
Baeke, Femke ;
Takiishi, Tatiana ;
Korf, Hannelie ;
Gysemans, Conny ;
Mathieu, Chantal .
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) :482-496
[6]   HYDROXYCHLOROQUINE TREATMENT OF HYPERCALCEMIA IN A PATIENT WITH SARCOIDOSIS UNDERGOING HEMODIALYSIS [J].
BARRE, PE ;
GASCONBARRE, M ;
MEAKINS, JL ;
GOLTZMAN, D .
AMERICAN JOURNAL OF MEDICINE, 1987, 82 (06) :1259-1262
[7]   The impact of vitamin D deficiency on diabetes and cardiovascular risk [J].
Baz-Hecht, Merav ;
Goldfine, Allison B. .
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (02) :113-119
[8]  
Birmingham DJ, 2010, J AM SOC NEPHROL, V21, p624A
[9]   Vitamin D deficiency in patients with active systemic lupus erythematosus [J].
Borba, V. Z. C. ;
Vieira, J. G. H. ;
Kasamatsu, T. ;
Radominski, S. C. ;
Sato, E. I. ;
Lazaretti-Castro, M. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (03) :427-433
[10]   The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial [J].
Buyon, JP ;
Petri, MA ;
Kim, MY ;
Kalunian, KC ;
Grossman, J ;
Hahn, BH ;
Merrill, JT ;
Sammaritano, L ;
Lockshin, M ;
Alarcón, GS ;
Manzi, S ;
Belmont, HM ;
Askanase, AD ;
Sigler, L ;
Dooley, MA ;
Von Feldt, J ;
McCune, WJ ;
Friedman, A ;
Wachs, J ;
Cronin, M ;
Hearth-Holmes, M ;
Tan, M ;
Licciardi, F .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :953-962